KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Other financing activities (2018 - 2025)

Guardant Health (GH) has disclosed Other financing activities for 8 consecutive years, with -$8.7 million as the latest value for Q4 2025.

  • Quarterly Other financing activities fell 14833.9% to -$8.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.6 million through Dec 2025, up 2450.33% year-over-year, with the annual reading at $3.6 million for FY2025, 2450.33% up from the prior year.
  • Other financing activities hit -$8.7 million in Q4 2025 for Guardant Health, down from $12.3 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $21.3 million in Q2 2023 to a low of -$20.5 million in Q4 2023.
  • Historically, Other financing activities has averaged $164785.7 across 5 years, with a median of -$29500.0 in 2022.
  • Biggest five-year swings in Other financing activities: crashed 113666.67% in 2023 and later soared 5917.45% in 2025.
  • Year by year, Other financing activities stood at -$784000.0 in 2021, then surged by 97.7% to -$18000.0 in 2022, then plummeted by 113666.67% to -$20.5 million in 2023, then surged by 100.29% to $59000.0 in 2024, then tumbled by 14833.9% to -$8.7 million in 2025.
  • Business Quant data shows Other financing activities for GH at -$8.7 million in Q4 2025, $12.3 million in Q3 2025, and -$41000.0 in Q2 2025.